HP
BLU

HealthInvest Partners’s BELLUS Health Inc. BLU Stock Holding History

HealthInvest Partners’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$8.84K Buy
+1,075
New +$10K 0.02% 41

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

HealthInvest Partners's BLU Position: Q4 2022 in Review

HealthInvest Partners opened a new position in BELLUS Health Inc. (BLU) in Q4 2022: 1,075 shares worth $8.84K. The stake represents 0.02% of the portfolio and ranks #41 among its holdings.

121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • HealthInvest Partners held 1,075 shares of BELLUS Health Inc. worth $8.84K as of Q4 2022.
  • BELLUS Health Inc. was a new HealthInvest Partners position in Q4 2022.
  • BELLUS Health Inc. made up 0.02% of HealthInvest Partners's portfolio in Q4 2022, its #41 holding.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.